Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02059057 · ClinicalTrials.gov registry record · NA
LVRC IDE Crossover Study (Crossover From IDE Trial CLN0009)
A NA study, sponsored by Boston Scientific Corporation.
- Terminated
- Registry status
- NA
- Development phase
- 102
- Enrollment target
NCT02059057 is a NA study that was terminated before completion, run by Boston Scientific Corporation. The registered enrollment target is 102 participants.
The verdict
NCT02059057, a NA study, was terminated before completion, sponsored by Boston Scientific Corporation.
- TERMINATED
- Registry status
- NA
- Development phase
- 102 participants
- Enrollment target
Study Summary
Crossover study for patients who were randomized to the Control Group in CLN0009 (NCT01608490).
Interventions
- DEVICE LVRC System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2013-12 |
| Est. Completion | 2019-07-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02059057
The ClinicalTrials.gov registry entry for NCT02059057 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which LVRC System is the first listed.
NCT02059057 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02059057 about?
NCT02059057 is a clinical study titled "LVRC IDE Crossover Study (Crossover From IDE Trial CLN0009)". Crossover study for patients who were randomized to the Control Group in CLN0009 (NCT01608490).
What is the current status of trial NCT02059057?
This trial is currently terminated. It is a NA study. The enrollment target is 102 participants. The study started on 2013-12. Estimated completion is 2019-07-26.
What interventions are being tested in trial NCT02059057?
The interventions under investigation include: LVRC System (DEVICE).
Who is sponsoring clinical trial NCT02059057?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.